Skip to main content

#161587

Plasmax™, Glucose-Free Cell Culture Medium

Cat. #161587

Plasmax™, Glucose-Free Cell Culture Medium

Cat. #: 161587

Sub-type: Cell culture media

Unit size: 500 ml

Availability: 6-8 weeks

Application: Cell culture; Cell growth and viability; Glucose starvation experiments; Cancer metabolism studies; Metabolic flux analysis

Volume: 500 ml

£120.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Saverio Tardito

Institute: CRUK Scotland Institute

Primary Citation: Vande Voorde et al. 2019. Sci Adv. 5(1):eaau7314. PMID: 30613774

Tool Details
Handling
Application Details
Related Tools
References
Documentation

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Tool name: Plasmax™, Glucose-Free Cell Culture Medium
  • Alternate name: Customised PlasmaxTM
  • Research fields: Cancer;Cell biology
  • Tool sub type: Cell culture media
  • Purpose: A tailored cell culture solution based on physiologically relevant cell culture medium which mimics the metabolic and physiological profile of human plasma
  • Formulation: PlasmaxTM cell culture media (Cat.# 156371) formulation without glucose. The PlasmaxTM cell culture media (Cat.# 156371) formulation can be found here.
  • Application: Cell culture; Cell growth and viability; Glucose starvation experiments; Cancer metabolism studies; Metabolic flux analysis

Handling

  • Format: Liquid
  • Volume: 500 ml
  • Storage conditions: Stable until expiry date on label

Application Details

  • Application: Cell culture; Cell growth and viability; Glucose starvation experiments; Cancer metabolism studies; Metabolic flux analysis
  • Application notes: The customised version of PlasmaxTM is created to fit your experiment’s unique requirements

Related Tools

  • Related tools: 156371

References

  • Bagshawet al. Mitochondrial Intoxication. 2023, 723-744
  • Gassl et al. Cancers (Basel) 2022 Nov 16,14(22):5617. PMID: 36428711
  • Wang et al. Biomolecules 2022 Oct 27,12(11):1575. PMID: 36358924
  • Villar et al. 2022. Nat Chem Biol. PMID: 36280791
  • Gardner et al. 2022. Am J Physiol Cell Physiol 323(3):C823-C834. PMID: 35876286
  • Golikov et al. 2022. Mol Biol (Mosk) 56(5):687-696. PMID: 36165010
  • Taurino et al. 2022. Mol Metab. 101532 PMID: 35752287
  • Wang et al. 2022. Biomolecules. 12(6):743. PMID: 35740868
  • Bagshaw et al. 2021. Biomaterials and Biosystems.4 (100027): 2666-5344
  • Golikov et al. 2022. Antioxidants 2022, 11, 97.
  • Golikov et al. Antioxidants 2022, 11(1), 97
  • Kalimuthu et al. 2021. J Cell Biochem. :. PMID: 34935169.
  • Hennequart et al. 2021. Nature Communications. 12: 6176.
  • Chiu et al. 2021. American Society of Hematology. Blood Advances.
  • Cox et al. 2020. Journal of Data and Information Science. 5(3): 161-177
  • Moradi et al. 2021. Biomolecules. 11(8): 1177
  • Plasmax Application Note
  • Barekatain et al. 2021. Nature. 12: 4228.
  • Moradi et al. 2021. American Journal of Physiology. Cell Physiology. 321 (1): C72-C81.
  • Khadka et al. 2021. Cancer & Metabolism. 9:27
  • Abbas et al. 2021. Comp Biochem Physiol B Biochem Mol Biol. 254:110570. PMID: 33516822.
  • PlasmaxTM: Product Brochure
  • Ackermann et al. 2019. Trends Cancer. 5(6):329-332. PMID: 31208694.
  • Cell culture shock – a scientist’s hunt for the perfect cocktail
  • Vande Voorde et al. 2019. Sci Adv. 5(1):eaau7314. PMID: 30613774.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.